Development and testing of a tool to assess patient preferences for phase I clinical trial participation.
作者信息
Pentz Rebecca D, Hendershot Kristopher A, Wall Louisa, White Taylor E, Peterson Susan K, Thomas Cheryl B, McCormick Jennifer, Green Michael J, Lewis Colleen, Farmer Zachary Luke, Hlubocky Fay J, Dossul Tehseen, Dixon Margie D, Liu Yuan, Switchenko Jeffrey M, Salvador Carolina, Owonikoko Taofeek K, Harvey R Donald, Khuri Fadlo R
机构信息
Emory University School of Medicine, Atlanta, GA, USA.
Winship Cancer Institute, Atlanta, GA, USA.
出版信息
Psychooncology. 2015 Jul;24(7):835-8. doi: 10.1002/pon.3731. Epub 2014 Dec 19.
Abstract
摘要
相似文献
1
Development and testing of a tool to assess patient preferences for phase I clinical trial participation.一种用于评估患者参与I期临床试验偏好的工具的开发与测试。
Psychooncology. 2015 Jul;24(7):835-8. doi: 10.1002/pon.3731. Epub 2014 Dec 19.
2
Realizing better doctor-patient dialogue about choices in palliative care and early phase clinical trial participation: towards an online value clarification tool (OnVaCT).实现更好的关于姑息治疗和早期临床试验参与选择的医患对话：迈向在线价值澄清工具（OnVaCT）。
BMC Palliat Care. 2019 Nov 29;18(1):106. doi: 10.1186/s12904-019-0486-6.
3
Performance-based readability testing of participant materials for a phase I trial: TGN1412.基于性能的 I 期临床试验参与者材料的可读性测试：TGN1412。
J Med Ethics. 2009 Sep;35(9):573-8. doi: 10.1136/jme.2008.026708.
4
Communication with the patient in clinical research.临床研究中与患者的沟通。
Ann N Y Acad Sci. 1997 Feb 20;809:83-96. doi: 10.1111/j.1749-6632.1997.tb48072.x.
5
Phase 1 healthy volunteer willingness to participate and enrollment preferences.I 期健康志愿者参与意愿和入组偏好。
Clin Trials. 2017 Oct;14(5):537-546. doi: 10.1177/1740774517722131. Epub 2017 Aug 2.
6
Phase I cancer trials. A collusion of misunderstanding.I期癌症试验。误解的交织。
Hastings Cent Rep. 2000 Jul-Aug;30(4):34-43.
7
Evaluating the impact of the Patient Preference Assessment Tool on clinicians' recommendations for phase I oncology clinical trials.评估患者偏好评估工具对肿瘤 I 期临床试验临床医生推荐的影响。
Psychooncology. 2021 Oct;30(10):1739-1744. doi: 10.1002/pon.5739. Epub 2021 May 31.
8
Characteristics, Motivations, and Preferences of Healthy Volunteers in Phase I Clinical Trials in Sweden.瑞典I期临床试验中健康志愿者的特征、动机和偏好
J Empir Res Hum Res Ethics. 2025 Feb-Apr;20(1-2):59-70. doi: 10.1177/15562646241309142. Epub 2025 Jan 27.
9
[Phase I clinical trials in oncology: a moral dilemma for the investigators].[肿瘤学中的I期临床试验：研究者面临的道德困境]
Presse Med. 2003 Feb 1;32(4):147-8.
10
Development of a questionnaire to assess communication preferences of patients with chronic illness.评估慢性病患者沟通偏好问卷的编制。
Patient Educ Couns. 2011 Jan;82(1):81-8. doi: 10.1016/j.pec.2010.02.011. Epub 2010 Mar 12.
引用本文的文献
1
Advances in Treatment of Recurrent Small Cell Lung Cancer (SCLC): Insights for Optimizing Patient Outcomes from an Expert Roundtable Discussion.复发性小细胞肺癌（SCLC）治疗进展：专家圆桌讨论洞察如何优化患者结局。
Adv Ther. 2021 Nov;38(11):5431-5451. doi: 10.1007/s12325-021-01909-1. Epub 2021 Sep 26.
2
Evaluating the impact of the Patient Preference Assessment Tool on clinicians' recommendations for phase I oncology clinical trials.评估患者偏好评估工具对肿瘤 I 期临床试验临床医生推荐的影响。
Psychooncology. 2021 Oct;30(10):1739-1744. doi: 10.1002/pon.5739. Epub 2021 May 31.
3
Reply to Helping patients to understand terrifying news: Addressing the inner lives of physicians and extending beyond what we know.对《帮助患者理解可怕的消息：关注医生的内心世界并超越我们的所知》的回复
Cancer. 2020 Jun 1;126(11):2714-2716. doi: 10.1002/cncr.32766. Epub 2020 Feb 19.
4
Why many oncologists fail to share accurate prognoses: They care deeply for their patients.为何许多肿瘤学家未能给出准确的预后信息：他们深切关心自己的患者。
Cancer. 2020 Mar 15;126(6):1163-1165. doi: 10.1002/cncr.32635. Epub 2019 Nov 27.
5
Description of the types and content of phase 1 clinical trial consent conversations in practice.实践中1期临床试验知情同意谈话的类型及内容描述。
Clin Trials. 2015 Dec;12(6):567-74. doi: 10.1177/1740774515601679. Epub 2015 Aug 28.
本文引用的文献
1
Patients rate physician communication about lung cancer.患者评价医生关于肺癌的沟通情况。
Cancer. 2011 Nov 15;117(22):5212-20. doi: 10.1002/cncr.26152. Epub 2011 Apr 14.
2
American society of clinical oncology statement: toward individualized care for patients with advanced cancer.美国临床肿瘤学会声明：为晚期癌症患者实现个体化护理。
J Clin Oncol. 2011 Feb 20;29(6):755-60. doi: 10.1200/JCO.2010.33.1744. Epub 2011 Jan 24.
3
Identifying patient information needs about cancer clinical trials using a Question Prompt List.使用问题提示清单识别癌症临床试验中患者的信息需求。
Patient Educ Couns. 2011 Jul;84(1):69-77. doi: 10.1016/j.pec.2010.07.005. Epub 2010 Aug 2.
4
An intervention to improve cancer patients' understanding of early-phase clinical trials.一项旨在提高癌症患者对早期临床试验理解的干预措施。
IRB. 2009 May-Jun;31(3):1-10.
5
Clinician and cancer patient views on patient participation in treatment decision-making: a quantitative and qualitative exploration.临床医生和癌症患者对患者参与治疗决策的看法：一项定量与定性探索
Br J Cancer. 2008 Sep 16;99(6):875-82. doi: 10.1038/sj.bjc.6604611.
6
Interventions to improve research participants' understanding in informed consent for research: a systematic review.提高研究参与者对研究知情同意理解的干预措施：一项系统综述
JAMA. 2004 Oct 6;292(13):1593-601. doi: 10.1001/jama.292.13.1593.
7
Ethics of phase 1 oncology studies: reexamining the arguments and data.肿瘤学1期研究的伦理学：重新审视相关论据和数据。
JAMA. 2003 Aug 27;290(8):1075-82. doi: 10.1001/jama.290.8.1075.
8
Accuracy of primary care and hospital-based physicians' predictions of elderly outpatients' treatment preferences with and without advance directives.基层医疗和医院医生对有和没有预先指示的老年门诊患者治疗偏好预测的准确性。
Arch Intern Med. 2001 Feb 12;161(3):431-40. doi: 10.1001/archinte.161.3.431.
9
More talk, less paper: predicting the accuracy of substituted judgments.多交流，少用纸：预测替代判断的准确性。
Am J Med. 1994 May;96(5):432-8. doi: 10.1016/0002-9343(94)90170-8.
10
Informed consent for phase I studies: evaluation of quantity and quality of information provided to patients.I期研究的知情同意：对向患者提供信息的数量和质量的评估。
Ann Oncol. 1995 Apr;6(4):363-9. doi: 10.1093/oxfordjournals.annonc.a059185.
Zotero 插件